Literature DB >> 26581281

Cannabis: debated schizophrenia link.

Matthew Large1, Marta Di Forti2, Robin Murray2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26581281     DOI： 10.1038/527305e

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  4 in total

1.  Perspective: Be clear about the real risks.

Authors:  Matthew Hill
Journal:  Nature       Date:  2015-09-24       Impact factor: 49.962

2.  Trends in cannabis use prior to first presentation with schizophrenia, in South-East London between 1965 and 1999.

Authors:  J Boydell; J van Os; A Caspi; N Kennedy; E Giouroukou; P Fearon; M Farrell; R M Murray
Journal:  Psychol Med       Date:  2006-07-20       Impact factor: 7.723

3.  Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users.

Authors:  Marta Di Forti; Conrad Iyegbe; Hannah Sallis; Anna Kolliakou; M Aurora Falcone; Alessandra Paparelli; Miriam Sirianni; Caterina La Cascia; Simona A Stilo; Tiago Reis Marques; Rowena Handley; Valeria Mondelli; Paola Dazzan; Carmine Pariante; Anthony S David; Craig Morgan; John Powell; Robin M Murray
Journal:  Biol Psychiatry       Date:  2012-07-24       Impact factor: 13.382

Review 4.  Why do patients with psychosis use cannabis and are they ready to change their use?

Authors:  Anna Kolliakou; Candice Joseph; Khalida Ismail; Zerrin Atakan; Robin M Murray
Journal:  Int J Dev Neurosci       Date:  2010-12-21       Impact factor: 2.457
  4 in total
  2 in total

1.  Cannabis use and risk of schizophrenia: a Mendelian randomization study.

Authors:  J Vaucher; B J Keating; A M Lasserre; W Gan; D M Lyall; J Ward; D J Smith; J P Pell; N Sattar; G Paré; M V Holmes
Journal:  Mol Psychiatry       Date:  2017-01-24       Impact factor: 15.992

2.  Are cannabis-using and non-using patients different groups? Towards understanding the neurobiology of cannabis use in psychotic disorders.

Authors:  Musa Basseer Sami; Sagnik Bhattacharyya
Journal:  J Psychopharmacol       Date:  2018-03-29       Impact factor: 4.153
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.